(Q36153584)

12 August 2017

Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome (English)

1 reference

12 August 2017

1 reference

1 reference

S Fujinaga

1

1 reference

12 August 2017

K Kaneko

2

1 reference

12 August 2017

T Muto

3

1 reference

12 August 2017

Y Ohtomo

4

1 reference

12 August 2017

H Murakami

5

1 reference

12 August 2017

Y Yamashiro

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

2 May 2006

1 reference

Archives of Disease in Childhood

12 August 2017

1 reference

12 August 2017

91

1 reference

12 August 2017

8

1 reference

12 August 2017

666-670

1 reference

Patient management by Neoral C(2) monitoring: an international consensus statement

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083035

Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083035

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083035

Cyclosporin A in nephrotic syndrome of childhood--a 14 month experience.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083035

Cyclosporine A induced remission of relapsing nephrotic syndrome in children.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083035

High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083035

Switch from cyclosporine A to mycophenolate mofetil in nephrotic children

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083035

Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083035

Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083035

Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083035

Comparison between pre- and posttreatment renal biopsies in children receiving ciclosporine for idiopathic nephrosis.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2083035

Comparison between pre- and posttreatment clinical and renal biopsies in children receiving low dose ciclosporine-A for 2 years for steroid-dependent nephrotic syndrome

23 September 2018

1 reference

12 December 2020

Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Preprandial C2 monitoring of cyclosporine treatment in children with nephrotic syndrome

1 reference

12 December 2020

Long-term clinical and pathological effects of cyclosporin in children with nephrosis

1 reference

12 December 2020

Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Recovery from cyclosporine-associated arteriolopathy in childhood nephrotic syndrome

1 reference

12 December 2020

Gonadal function in boys with steroid-responsive nephrotic syndrome treated with cyclophosphamide for short periods

1 reference

12 December 2020

Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence

1 reference

12 December 2020

Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children

1 reference

12 December 2020

Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children

1 reference

12 December 2020

Age-dependent cyclosporine: pharmacokinetics in marrow transplant recipients

1 reference

12 December 2020

Ciclosporin treatment in children with steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Does kL/PCr estimate GFR, or does GFR determine k?

1 reference

12 December 2020

Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies

1 reference

12 December 2020

Cyclosporine in the treatment of idiopathic nephrosis

1 reference

12 December 2020

Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis

1 reference

12 December 2020

A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children

1 reference

12 December 2020

Identifiers

DOI

10.1136/ADC.2005.080960

1 reference

12 August 2017

1 reference

12 August 2017

1 reference